Chicos FAS Inc (CHS)

US1686151028 - Common Stock

7.59  -0.01 (-0.13%)

After market: 7.591 +0 (+0.01%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CHS. CHS was compared to 126 industry peers in the Specialty Retail industry. Both the profitability and the financial health of CHS get a neutral evaluation. Nothing too spectacular is happening here. CHS has a valuation in line with the averages, but on the other hand it scores bad on growth.



6

1. Profitability

1.1 Basic Checks

CHS had positive earnings in the past year.
CHS had a positive operating cash flow in the past year.
In multiple years CHS reported negative net income over the last 5 years.
Of the past 5 years CHS 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 8.82%, CHS is in the better half of the industry, outperforming 79.84% of the companies in the same industry.
CHS has a Return On Equity of 26.40%. This is in the better half of the industry: CHS outperforms 79.84% of its industry peers.
CHS's Return On Invested Capital of 12.31% is fine compared to the rest of the industry. CHS outperforms 77.52% of its industry peers.
Industry RankSector Rank
ROA 8.82%
ROE 26.4%
ROIC 12.31%
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CHS has a better Profit Margin (5.29%) than 72.87% of its industry peers.
In the last couple of years the Profit Margin of CHS has grown nicely.
CHS has a Operating Margin of 6.16%. This is in the better half of the industry: CHS outperforms 68.22% of its industry peers.
CHS's Operating Margin has improved in the last couple of years.
CHS's Gross Margin of 38.94% is in line compared to the rest of the industry. CHS outperforms 59.69% of its industry peers.
In the last couple of years the Gross Margin of CHS has remained more or less at the same level.
Industry RankSector Rank
OM 6.16%
PM (TTM) 5.29%
GM 38.94%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHS is still creating some value.
The number of shares outstanding for CHS has been increased compared to 1 year ago.
Compared to 5 years ago, CHS has less shares outstanding
CHS has a better debt/assets ratio than last year.

2.2 Solvency

CHS has an Altman-Z score of 3.22. This indicates that CHS is financially healthy and has little risk of bankruptcy at the moment.
CHS's Altman-Z score of 3.22 is fine compared to the rest of the industry. CHS outperforms 70.54% of its industry peers.
The Debt to FCF ratio of CHS is 0.42, which is an excellent value as it means it would take CHS, only 0.42 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CHS (0.42) is better than 82.17% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that CHS is not too dependend on debt financing.
CHS has a better Debt to Equity ratio (0.06) than 75.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.42
Altman-Z 3.22
ROIC/WACC1.34
WACC9.19%

2.3 Liquidity

CHS has a Current Ratio of 1.20. This is a normal value and indicates that CHS is financially healthy and should not expect problems in meeting its short term obligations.
CHS's Current ratio of 1.20 is on the low side compared to the rest of the industry. CHS is outperformed by 72.09% of its industry peers.
A Quick Ratio of 0.42 indicates that CHS may have some problems paying its short term obligations.
CHS's Quick ratio of 0.42 is on the low side compared to the rest of the industry. CHS is outperformed by 60.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.42

2

3. Growth

3.1 Past

The earnings per share for CHS have decreased strongly by -15.38% in the last year.
Measured over the past 5 years, CHS shows a small growth in Earnings Per Share. The EPS has been growing by 4.10% on average per year.
CHS shows a decrease in Revenue. In the last year, the revenue decreased by -0.24%.
The Revenue has been decreasing by -1.26% on average over the past years.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS growth Q2Q-45%
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Revenue growth Q2Q-2.54%

3.2 Future

CHS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.47% yearly.
CHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.60% yearly.
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.86 indicates a reasonable valuation of CHS.
Based on the Price/Earnings ratio, CHS is valued a bit cheaper than the industry average as 79.07% of the companies are valued more expensively.
CHS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.92.
With a Price/Forward Earnings ratio of 10.29, the valuation of CHS can be described as very reasonable.
CHS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CHS is cheaper than 74.42% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CHS to the average of the S&P500 Index (21.49), we can say CHS is valued rather cheaply.
Industry RankSector Rank
PE 9.86
Fwd PE 10.29

4.2 Price Multiples

85.27% of the companies in the same industry are more expensive than CHS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CHS is valued a bit cheaper than 67.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.37
EV/EBITDA 4.72

4.3 Compensation for Growth

The decent profitability rating of CHS may justify a higher PE ratio.
A cheap valuation may be justified as CHS's earnings are expected to decrease with -8.47% in the coming years.
PEG (NY)N/A
PEG (5Y)2.41
EPS Next 2Y-8.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CHS!.
Industry RankSector Rank
Dividend Yield N/A

Chicos FAS Inc

NYSE:CHS (1/4/2024, 7:04:00 PM)

After market: 7.591 +0 (+0.01%)

7.59

-0.01 (-0.13%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap937.06M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 9.86
Fwd PE 10.29
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)2.41
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 26.4%
ROCE
ROIC
ROICexc
ROICexgc
OM 6.16%
PM (TTM) 5.29%
GM 38.94%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.2
Quick Ratio 0.42
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-18.51%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y